Why is Bayit Bakfar Ltd. ?
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 2.64%
- Poor long term growth as Net Sales has grown by an annual rate of 6.69% and Operating profit at 6.68%
2
With ROE of 2.40%, it has a Very Expensive valuation with a 0.82 Price to Book Value
- Over the past year, while the stock has generated a return of -5.80%, its profits have risen by 11.2% ; the PEG ratio of the company is 3
3
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -5.80% returns in the last 1 year, the stock has also underperformed Israel TA-100 in each of the last 3 annual periods
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Bayit Bakfar Ltd. for you?
Medium Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Bayit Bakfar Ltd.
-6.46%
1.18
29.57%
Israel TA-100
39.36%
2.05
19.19%
Quality key factors
Factor
Value
Sales Growth (5y)
6.69%
EBIT Growth (5y)
6.68%
EBIT to Interest (avg)
3.26
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.09
Tax Ratio
23.51%
Dividend Payout Ratio
28.11%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.08%
ROE (avg)
2.64%
Valuation Key Factors 
Factor
Value
P/E Ratio
34
Industry P/E
Price to Book Value
0.82
EV to EBIT
17.84
EV to EBITDA
17.56
EV to Capital Employed
0.78
EV to Sales
7.35
PEG Ratio
3.04
Dividend Yield
2.97%
ROCE (Latest)
4.37%
ROE (Latest)
2.40%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Mildly Bullish






